Production (Stage)
Cryo-Cell International, Inc.
CCEL
$4.83
$0.030.63%
AMEX
| 02/28/2025 | 11/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.69% | -0.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.69% | -0.53% | |||
| Cost of Revenue | 21.26% | -23.01% | |||
| Gross Profit | -6.32% | 7.52% | |||
| SG&A Expenses | -22.83% | 44.84% | |||
| Depreciation & Amortization | -2.09% | 0.72% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.16% | 22.26% | |||
| Operating Income | 955.75% | -108.80% | |||
| Income Before Tax | 163.35% | -161.05% | |||
| Income Tax Expenses | -75.38% | 210.54% | |||
| Earnings from Continuing Operations | 115.20% | -277.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 115.20% | -277.01% | |||
| EBIT | 955.75% | -108.80% | |||
| EBITDA | 938.22% | -92.38% | |||
| EPS Basic | 115.16% | -276.99% | |||
| Normalized Basic EPS | 165.32% | -199.11% | |||
| EPS Diluted | 113.00% | -277.54% | |||
| Normalized Diluted EPS | 164.42% | -200.60% | |||
| Average Basic Shares Outstanding | 0.19% | 0.06% | |||
| Average Diluted Shares Outstanding | 1.65% | -1.31% | |||
| Dividend Per Share | 0.00% | -- | |||
| Payout Ratio | 7.58% | -- | |||